June 25, 2019
FDA: Class I recall of Hudson RCI Sheridan, Sheridan Endotracheal Tubes
Editor's Note
The Food & Drug Administration on June 21 identified the recall by Teleflex Medical (Wayne, Pennsylvania) of the Hudson RCI Sheridan and Sheridan Endotracheal Tubes as Class I, the most serious.
The recall was initiated because of the risk of the Sheridan connector disconnecting from the breathing circuit.
The company has received 179 complaints with 192 occurrences related to the disconnection, including two deaths and one injury.
Distribution dates were October 2016 to May 2019.
Free Daily News
- Hospital addresses barriers to patient rest, recovery
- Study: Psilocybin therapy reduces depression in frontline clinicians
- Exclusive articles preview OR Business Management Conference sessions
- Study: Surgeries improve survival in young BRCA-positive breast cancer patients
- Study: Advanced recovery room care could reduce long-term postoperative mortality
- FDA designates Class 1 recalls for balloon catheters, radiographic markers
- Orthopedic surgery in 2025: Embracing innovation, preserving autonomy
- Medtronic, Zimmer Biomet challenge Intuitive Surgical’s robotic surgery dominance
- Anthem’s anesthesia time limit policy, reversal sparks new legislation
- Simple procedure or ‘surgery’? Questionable medical billing practices cause confusion
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement